Cargando…
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors
Mortality from prostate cancer (PCa) is due to the formation of metastatic disease. Understanding how that process is regulated is therefore critical. We previously demonstrated that endoglin, a type III transforming growth factor β (TGFβ) superfamily receptor, suppresses human PCa cell invasion and...
Autores principales: | Breen, Michael J., Moran, Diarmuid M., Liu, Wenzhe, Huang, Xiaoke, Vary, Calvin P. H., Bergan, Raymond C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742533/ https://www.ncbi.nlm.nih.gov/pubmed/23967299 http://dx.doi.org/10.1371/journal.pone.0072407 |
Ejemplares similares
-
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
por: Olsen, O E, et al.
Publicado: (2014) -
Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling
por: Xie, Chen, et al.
Publicado: (2020) -
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
por: Ganjoo, Shonik, et al.
Publicado: (2022) -
Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor
por: Liu, Yuhang, et al.
Publicado: (2021) -
An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension
por: Ryanto, Gusty R. T., et al.
Publicado: (2021)